2017

XThis page contains elements that are not optimised for mobile viewing. Click the link below to view the page in desktop mode.

Desktop mode

Go to main content

Consultation on the reimbursement status of medicinal products in ATC group A06 (laxatives) and A02AA04 (magnesium hydroxide)

| 04 May 2009 |

At the Danish Medicines Agency's request, the Reimbursement Committee has reassessed the reimbursement status of medicinal products authorised for marketing in Denmark in ATC group A06 (laxatives) and A02AA04 (magnesium hydroxide)